AbCellera Biologics Inc. Common Shares (NASDAQ: ABCL) last traded at $11.32, down 2.16% on the session. The quote above updates while this page is open; the figures below are drawn from AbCellera Biologics Inc. Common Shares’s own filings and are restated only when a new one is published.
AbCellera Biologics Inc. Common Shares trades on NASDAQ under the ticker ABCL. Its market capitalisation is $3.47 billion.
Valuation measures for AbCellera Biologics Inc. Common Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.47B |
|---|---|
| Enterprise value | $3.76B |
| Price / sales | 52.45 |
| Price / book | 3.87 |
| Beta | 2.62 |
Trailing-twelve-month figures tagged in AbCellera Biologics Inc. Common Shares's XBRL filings with the SEC.
| Revenue (TTM) | $66.17M |
|---|---|
| Net income (TTM) | -$164.66M |
| EPS (TTM) | -$0.540 |
| Operating margin | -340.25% |
| Return on equity | -18.38% |
| Cash | $120.06M |
Range and volume for ABCL over the past 52 weeks.
| 52-week high | $12.15 |
|---|---|
| 52-week low | $2.75 |
| Volume | 4.54M |
| Average volume | 8.00M |
| Previous close | $11.57 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.